So who's actually the best for semaglutide?

One of the older, larger weight-care platforms — Found (Found Health Inc., joinfound.com) has operated since 2019 and reports 250,000+ members. Care is led by obesity-medicine clinicians and paired with a behavioral-coaching app, community and insurance navigation rather than medication alone. Its stand-out is breadth of formulary: compounded semaglutide at the entry, but also a genuine brand-name path (Wegovy, Ozempic) and oral Rybelsus (oral semaglutide), plus non-GLP oral options, all in 50 states with HSA/FSA accepted. The trade-off is pricing that varies and layers — the headline compounded rate (as low as $99/mo) needs a 3–12 month prepay, month-to-month lands nearer $199–$299/mo, and the brand path stacks a ~$39/mo membership on top of the drug.

A budget-first telehealth brand: you complete an online intake, a licensed clinician signs off, and compounded semaglutide ships to your door — free shipping, all 50 states. Trimi's whole pitch is a low, plainly-stated monthly price, and it stocks both GLP-1 molecules (semaglutide and tirzepatide) so you can switch tracks later without moving to a new provider. It is leaner on hand-holding than CoreAge — the low price buys you the medicine and clinician sign-off more than a bundled coaching program.

Gala's GLP-1 program (operated by AI Coaching Inc.) runs an online intake with clinician review and ships nationwide — it is one of the few telehealth brands we log that covers all 50 states. It pairs a low-cost compounded entry point with an actual brand-name path: if you want FDA-approved semaglutide it can route you to Ozempic, though that runs about $1,299/month cash. There is a menopause/HRT track alongside weight care, but no oral semaglutide option yet.

A compounded-only telehealth brand that leans on clear, published tiers rather than a hidden membership. Compounded semaglutide is $212/month — with a discounted $112 first month — and the price does not step up as you titrate to a higher dose. Care includes provider oversight and lab testing on a roughly six-month cadence, and there's a NAD+ add-on for people who want the longevity adjacency. It carries no brand-name or oral option, and it does not publish which states it serves.

A physician-supervised telehealth clinic for medical weight loss whose stand-out credential is LegitScript certification (#50087439) — an independent verification most compounded-semaglutide sellers do not carry. It fills compounded semaglutide (and tirzepatide) from U.S. pharmacies with transparent, no-insurance monthly pricing, and is one of the few brands we log that offers an oral semaglutide tablet alongside the usual injectable. The trade-offs are the usual compounded caveat plus a thin public site: some tiers are company-stated, the brand Ozempic route is an expensive pass-through, and the serviced-state count is not published.

A newer (2024) compounded-only telehealth brand whose pitch is format choice: it offers oral/sublingual compounded semaglutide as well as the usual injectable, which is unusual, plus both molecules (semaglutide and tirzepatide). Pricing is all-inclusive with no separate membership. The trade-off is verifiability — the figures are company-stated rather than something we could confirm live, the brand operates across multiple domains, and it has a short public history.

A compounded GLP-1 and longevity telehealth brand ("A New Era of Personalized Health") that publishes its prices openly rather than hiding them behind a quiz — a genuine plus, since many compounded rivals do not. You complete an online intake, a licensed clinician reviews it, and compounded semaglutide (or tirzepatide) ships as a weekly injectable. It carries both GLP-1 molecules and layers on a wider wellness menu — NAD+ and microdosing protocols — plus an optional Optimum membership that adds 1:1 coaching, a nutritionist, at-home lab draws and wearables. yourEra markets a 50-state licensed-clinician network with no insurance required and HSA/FSA accepted. The trade-offs are mid-market pricing, a compounded-only and injectable-only lineup, and a thin independent footprint — its 50-state and efficacy claims are self-reported.

Telos Rx (operated by Superior Health Solutions LLC) is a broad compounded-telehealth platform whose standout credential is LegitScript certification — an independent verification that most compounded-semaglutide sellers simply do not carry. Beyond GLP-1 it runs a wide menu: semaglutide and tirzepatide in both oral and microdosed formats, intranasal NAD+, recovery and growth-hormone peptides, and bioidentical HRT. The GLP-1 headline is genuinely low — microdosed semaglutide from about $49/month and tirzepatide from about $99/month — but those figures are annual-plan rates, so the cheapest numbers require a 6–12 month commitment, and pricing outside the GLP-1 line is quote-based rather than posted.

Bodybuilding Health+ is the compounded-telehealth arm of Bodybuilding.com — a licensed brand extension operated by Dynamo Group LLC that launched around April 2026. You complete an online intake, an independent licensed provider reviews it, and compounded semaglutide or tirzepatide is filled by a U.S. compounding pharmacy. Its GLP-1 pricing is public and competitive: semaglutide is $179 the first month (regularly $279) and steps down to $139/month on a 12-month bundle, with tirzepatide on the same $139 floor. Around the GLP-1 line sits an unusually deep menu for the lifter/longevity crowd — NAD+, sermorelin, ED and a broad peptide catalog. The trade-offs are newness and policy: it is only months old with a thin, mixed review record, and prescription orders are final sale.

Online intake with a licensed provider, with compounded semaglutide shipped to your door if prescribed. The advertised $99/month covers medication only; an active Eden Membership is required and billed separately, so the real monthly outlay is the sum of the two.

Membership-based telehealth with access to a physician and dietitian plus nutrition coaching. Compounded injectable semaglutide is an add-on priced on top of the membership, so the total monthly cost is the membership fee plus the medication fee.

Large telehealth platform offering brand-name Wegovy, Ozempic and Zepbound (insurance or cash-pay) alongside other GLP-1 options. The Ro Body membership is billed on its own; the company states the cost of GLP-1 medication is not included and varies by treatment and insurance.

Large telehealth platform that, following a 2026 settlement with Novo Nordisk, has pivoted to brand-name FDA-approved options — Wegovy, oral Wegovy and Zepbound — as an authorized distribution channel (its legacy compounded semaglutide is being phased out by mid-2026). The membership is billed on its own; the medication is a separate cost on top, so there is no single flat figure.

Telehealth provider that prescribes compounded injectable and oral semaglutide filled through its pharmacy network, with clinician support and free shipping. Unlike a true flat plan, the monthly price steps up by about $100 once you pass the 1mg dose, and the lowest advertised figures require a longer-term bundle commitment.

Pairs clinical GLP-1 care — compounded semaglutide or brand-name Wegovy/Zepbound — with the all-inclusive Noom behavioral app. The introductory rate is attractive, but the standard program price steps up sharply to $349/month after the intro period, and the app value can make the underlying medication cost harder to see.

The clinical arm of WeightWatchers (formerly Sequence) pairs clinician care and the WW behavioral program with brand-name Wegovy, oral Wegovy, Saxenda and Zepbound — it dropped compounded GLP-1s in 2025. The program fee is separate from the medication, which is largely insurance-dependent, so your true monthly total depends on your coverage.